Effort to Prevent Nosocomial Pneumonia Caused by Pseudomonas Aeruginosa in Mechanically Ventilated Subjects
Status:
Completed
Trial end date:
2019-12-04
Target enrollment:
Participant gender:
Summary
Clinical trial looking to evaluate the efficacy and safety of MEDI3902 in mechanically
ventilated participants for the prevention of nosocomial pneumonia caused by Pseudomonas
aeruginosa.
Phase:
Phase 2
Details
Lead Sponsor:
MedImmune LLC
Collaborators:
Antibacterial Resistance Leadership Group INNOVATIVE MEDICINES INITIATIVE and COMBACTE-MAGNET National Institute of Allergy and Infectious Diseases (NIAID)